FDA's Regulation of Biomarkers - Turning the Critical Path
into a Yellow Brick Road
Pharmacogenomics Impact on Chronic Diseases
Stratifying the Disease and then Targeting the Therapeutic
The Future Prospects for Translational Medicine - Conducting
Chronic Disease Studies in India
Regulatory Initiatives in Place to Support Personalized Medicines
Development - Both US and Global
|
